Description
SINGLE UNIT DOSE RADIOPHARMACEUTICALS
First action · last action
2013-12-20 · 2015-03-23
Transactions
3
First transaction's obligation
$113,404
Base + all options value (sum of deltas)
$609,850
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
Parent IDV
VA25114D0026
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-12-20+$113,404= $113,404
- Mod P000012014-04-07+$2,850= $116,254
- Mod P000022015-03-23-$15,123= $101,131
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-12-20 | +$113,404 | $113,404 | SINGLE UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00001· CHANGE ORDER | 2014-04-07 | +$2,850 | $116,254 | SINGLE UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00002· CHANGE ORDER | 2015-03-23 | −$15,123 | $101,131 | SINGLE UNIT DOSE RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D6G2N35AECL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA25017J1012 | 553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS | $84,916 | FY2017 |
| VA25017J1010 | 583-INDIANAPOLIS(00583) · 6505 · DRUGS AND BIOLOGICALS | $63,371 | FY2017 |
| VA25116J0306 | 553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS | $174,718 | FY2016 |
| VA25116J0262 | 553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS | $112,861 | FY2016 |
| VA25115J0458 | 553-DETROIT (00553) · 6505 · DRUGS AND BIOLOGICALS | $137,350 | FY2015 |
| VA25115J0370 | 553-DETROIT · 6505 · DRUGS AND BIOLOGICALS | $117,675 | FY2015 |
Other recipients under 6505 from 553-DETROIT (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F1200 | ALEXION PHARMACEUTICALS INC | 553-DETROIT | $35,840 | FY2016 |
| VA25116F1203 | ACTELION PHARMACEUTICALS US, INC. | 553-DETROIT | $4,614 | FY2016 |
| VA25116F1198 | PFIZER INC | 553-DETROIT | $11,065 | FY2016 |
| VA25116F1088 | ALEXION PHARMACEUTICALS INC | 553-DETROIT | $35,840 | FY2016 |
| VA25116F0598 | PFIZER INC | 553-DETROIT | $11,065 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25114J0639_3600_VA25114D0026_3600 · retrieved 2026-09-27.